Kyndryl Shares Climb After Form 10-Q Filed; No Restatements Reported
Kyndryl's stock rose 10% after the company filed its Form 10-Q for the quarter ended Dec. 31, 2025, confirming there were no restatements of current or previously reported financial statements. The company also submitted amendments to its 2025 fiscal-year 10-K and two earlier 10-Qs, and disclosed material weaknesses in internal control over financi…